271 related articles for article (PubMed ID: 31045630)
1. Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease.
Dogan T; Ozturk K; Celikkanat S; Aykan MB; Uygun A
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1460-1466. PubMed ID: 31045630
[TBL] [Abstract][Full Text] [Related]
2. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
[TBL] [Abstract][Full Text] [Related]
3. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
4. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease.
Ozturk K; Dogan T; Celikkanat S; Ozen A; Demirci H; Kurt O; Turker T; Yilmaz Y; Uygun A
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):411-417. PubMed ID: 29309395
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
[TBL] [Abstract][Full Text] [Related]
6. Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score.
Xin Z; Zhu Y; Wang S; Liu S; Xu M; Wang T; Lu J; Chen Y; Zhao Z; Wang W; Ning G; Bi Y; Xu Y; Li M
Liver Int; 2020 Apr; 40(4):806-814. PubMed ID: 31820847
[TBL] [Abstract][Full Text] [Related]
7. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neck and waist circumferences for identifying subclinical atherosclerosis in a community-based population.
Xu Y; Jian C; Ma X; Shen Y; Wang Y; Bao Y
Diabetes Metab Res Rev; 2021 Jul; 37(5):e3382. PubMed ID: 32628319
[TBL] [Abstract][Full Text] [Related]
9. Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population.
Taharboucht S; Guermaz R; Brouri M; Chibane A
J Med Vasc; 2021 May; 46(3):129-138. PubMed ID: 33990287
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity.
Puig J; Blasco G; Daunis-I-Estadella J; Loshuertos E; Codina J; Cuba V; Ortiz R; Xifra G; Ricart W; Pedraza S; Federici M; Fernández-Real JM
Clin Endocrinol (Oxf); 2015 Aug; 83(2):180-6. PubMed ID: 25510350
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in fat distribution influence the association between BMI and arterial stiffness.
van den Munckhof ICL; Holewijn S; de Graaf J; Rutten JHW
J Hypertens; 2017 Jun; 35(6):1219-1225. PubMed ID: 28441693
[TBL] [Abstract][Full Text] [Related]
12. Comparison of anthropometric indices for the screening of nonalcoholic fatty liver disease in pre- and postmenopausal women.
Hong SH; Hwang SY; Kim JA; Lee YB; Roh E; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM; Baik SH; Yoo HJ
Menopause; 2020 Jan; 27(1):88-94. PubMed ID: 31613826
[TBL] [Abstract][Full Text] [Related]
13. Abdominal obesity and low-grade systemic inflammation as markers of subclinical organ damage in type 2 diabetes.
Dahlén EM; Tengblad A; Länne T; Clinchy B; Ernerudh J; Nystrom FH; Östgren CJ
Diabetes Metab; 2014 Feb; 40(1):76-81. PubMed ID: 24290615
[TBL] [Abstract][Full Text] [Related]
14. Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease.
Colak Y; Karabay CY; Tuncer I; Kocabay G; Kalayci A; Senates E; Ozturk O; Doganay HL; Enc FY; Ulasoglu C; Kiziltas S
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):613-8. PubMed ID: 22495402
[TBL] [Abstract][Full Text] [Related]
15. Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study.
Lankarani KB; Mahmoodi M; Lotfi M; Zamiri N; Heydari ST; Ghaffarpasand F; Fallahzadeh MK; Babaeinejad M; Maharlouei N; Mirzaee O; Geramizadeh B; Peymani P
Korean J Gastroenterol; 2013 Dec; 62(6):344-51. PubMed ID: 24365733
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.
Thakur ML; Sharma S; Kumar A; Bhatt SP; Luthra K; Guleria R; Pandey RM; Vikram NK
Atherosclerosis; 2012 Aug; 223(2):507-11. PubMed ID: 22748277
[TBL] [Abstract][Full Text] [Related]
17. Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes--a prospective observational cohort study.
Dahlén EM; Bjarnegård N; Länne T; Nystrom FH; Ostgren CJ
Cardiovasc Diabetol; 2013 Mar; 12():55. PubMed ID: 23536999
[TBL] [Abstract][Full Text] [Related]
18. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.
Kuang M; Sheng G; Hu C; Lu S; Peng N; Zou Y
Lipids Health Dis; 2022 Oct; 21(1):104. PubMed ID: 36266655
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis and Associated Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
Bajaj S; Prajapati SK
J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702845
[TBL] [Abstract][Full Text] [Related]
20. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
